Skip to main content
. 2001 Apr;132(7):1447–1454. doi: 10.1038/sj.bjp.0703958

Figure 3.

Figure 3

Changes in BP and TPR to the V1 receptor antagonist and bosentan in DOCA-salt hypertensive rats (DOCA) and SHAM control rats (SHAM). *P<0.05 compared to the antagonist pretreatment value and P<0.05 compared to response when V1 receptors were functional.